SCT200
Product Specifications
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis, JAK/STAT signaling
Bioactivity
SCT200 is a fully humanized IgG1 monoclonal antibody targeting EGFR, with a Kd value of 0.08 nM. It can eliminate tumor cells via complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) through its Fc fragment. SCT200 is utilized in research on refractory RAS and BRAF wild-type metastatic colorectal cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P50226G 1000 Units/Pack
Printed, assembled Screw Cap Tube, Self-Standing, PP, 0.5 mL, Sterile, with EPDM ring Cap, Green, DNase/RNase free- 1000 un. - ABDOS
Sign In for Pricing
View Details 
PROTP33896-100ug 100 µg
Mouse IFN-alpha/beta R1 Recombinant Protein
Sign In for Pricing
View Details 